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Macrophages have been implicated for many years as an important effector 
cell in host defense against a variety of facultative and obligate intracellular 
parasites (1-9). Their ability to spread, to phagocytize, and to display microbici- 
dal and tumoricidal effects are enhanced in the course of  these infections and the 
macrophages are said to be activated. Some of the activated macrophage proper- 
ties have been achieved in vitro by lymphocyte mediators (10). Prior studies of 
others have demonstrated the requirement of thymus-derived lymphocytes in 
the adoptive transfer of anti-bacterial immunity (11, 12). We have shown in the 
preceding paper that, in the course of BCG and Trypanosoma cruzi infection in 
mice, macrophages become activated as indicated by their enhanced spreading 
and phagocytic capacities, their ability to secrete plasminogen activator, and 
their ability to kill trypomastigotes of T. cruzi in vitro (13). 
In  this  paper,  we  report that  normal,  unstimulated macrophages can be 
activated in vitro by a  lymphocyte product(s) derived from the interaction of 
sensitized peritoneal or spleen cells with T.  cruzi  antigen.  This activation is 
expressed as the secretion of high levels of plasminogen activator and requires 
the participation of T lymphocytes. 
Materials and Methods 
Parasites.  The Y  strain of T.  cruzi  was obtained from Dr.  S.  C.  Correa,  Instituto Oswaldo 
Cruz, Rio  de  Janeiro,  Brazil,  and the Tulahu@n strain  from Dr. B. Bloom, Albert Einstein School 
of  Medicine, Bronx, N. Y. The parasites  were grown in Tobie's  medium and passed  weekly (14). 
Parasites were harvested from 8-day-old  cultures,  washed five  times with ice-cold  phosphate- 
buffered  saline  (PBS)  I  (Dulbecco's,  Grand Island  Biological  Co.,  Grand Island,  N. Y.) at  750g for 
15  min, resuspended  in  ice-cold  PBS or  Dulbecco's  modified Eagle's  medium (GIBCO), and  counted 
in a hemocytometer with a 40 x objective.  The cultures  of  Y strain  contained 85% epimastigotes 
and 15%  trypomastigotes.  The  Tulahu@n strain  contained 95% epimastigotes.  Purified  trypomasti- 
gotes  were obtained as previously  described (15). 
* Supported in part by grants AI 07012 and AI 12975 from the U. S. Public Health Service. 
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Abbreviations used in this paper: AT-DS, acid-treated dog serum; D2FBS, Dulbecco's medium 
containing 2% fresh fetal bovine serum plus 5  x  10  -5 M  mercaptoethanol; D1OFBS,  Dulbecco's 
medium containing 10% heat-inactivated fetal bovine serum plus 5  x  10 -5 M  mercaptoethanol; 
FBS, fetal bovine serum; HBSS,  Hanks' balanced salt solution; HKT,  heat-killed trypanosomes; 
ME,  mercaptoethanol; MIF,  migration inhibitory factor; PBS,  phosphate-buffered saline; PPD, 
purified protein derivative of tuberculin. 
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Cell Cultures 
NORMAL MACROPHAGES.  Mouse peritoneal macrophages were obtained from female Swiss mice 
maintained at The Rockefeller University, and C57BL/6J, A/J, and C3H/HeJ mice obtained from 
The Jackson Laboratory, Bar Harbor, Maine.  Cells were harvested according to the methods of 
Cohn and Benson (16).  They were cultivated on 13-ram round glass cover slips or in 125I-fibrin- 
coated 16-mm Linbre plates (Linbre Chemical Co., New Haven,  Conn.), prepared as previously 
described (17) in Dulbecco's medium and 2% fresh fetal bovine serum (FBS), 100 U/ml penicillin, 
and 100 tzg/ml streptomycin. 2  x  10  e total peritoneal cells were plated per well, 45-50% of which 
were macrophages. 
T. CRUZI-"PRIMRn"  PErJTONEAL CELLS.  NCS, C57BL/6J, A/J, and C3H/HeJ mice were infected 
intraperitoneally with 5  x  10  ~ live culture forms of T. cruzi, Y strain, in PBS. At several times 
after  the  infection,  peritoneal  cells  were  harvested,  usually  pooled  from  three  to  four  mice. 
Average yields were  10  x  106 cells per mouse,  from which 45-50% were  lymphocytes,  45-50% 
macrophages,  and about 5% polymorphonuclear leukocytes.  4  x  106 total peritoneal cells were 
plated on nonradiaoctive 16-mm Linbro plates in Dulbecco's medium plus 2% FBS,  5  x  10  -s M 
mercaptoethanol (ME) (D2FBS), 100 U/ml penicillin, 100 pg/ml streptomycin, and glutamine, in 
the presence of the desired antigen. 
T. CRUZI-PRIMED SPLEEN CELLS.  Spleens were  removed from three to four  mice infected as 
described above, pooled,  teased  with forceps,  and passed through a  sterile stainless steel wire 
mesh.  The  screen  was  washed  with  cold  medium,  and  the  cells  dispersed  by  pipetting  the 
suspension up and down several times. The cells were then washed once in cold D2FBS,  resus- 
pended at the desired concentration in the same medium,  and plated in nonradiaoctive Linbre 
plates in the presence of the desired antigen. 
NYLON-WOOL SEPARATION OF  LYMPHOCYTES.  Suspension  of spleen  or  peritoneal  cells  were 
obtained in Dulbecco's 10% heat-inactivated FBS plus 5  x  10 -5 M  ME (D10FBS) and overlayed on  a 
nylon-wool column (Fenwal Laboratories, Inc., Morton Grove, Ill.), preincubated with D10FBS at 
37°C for 1 h  (18).  The column containing the cells was then incubated at 37°C for 45 rain, and the 
cells eluted with 50 ml of D10FBS. The cells were washed once, counted, suspended to the desired 
concentration in D2FBS,  and plated on nonradioactive Linbro plates containing a  monolayer of 
normal macrophages (2  x  105 macrophages per well), in the presence of the desired antigen. 
ANTI-Thy  1.2  ANn  ANTI-K TREATMENT  OF SPLEEN  CELLS.  10  8 spleen cells were incubated for 20 
rain at 4°C in 1 ml of anti-Thy 1.2 serum (AKR anti-SBLE thymocytes) diluted 1:10 in Dulbeeco's 
medium  or  in  1  ml of anti-K  serum  (rabbit anti-K T-myeloma)  diluted  1:100  in  D2FBS.  Both 
antisera were kindly supplied by Dr.  U.  H/immerling of The Sloan-Kettering Cancer Institute, 
New York. The cells were centrifuged and incubated for 45 min at 37°C in 3 ml of a selected rabbit 
complement (C) (for anti-Thy 1.2 treatment) or guinea-pig C (for anti-K treatment) diluted 1:22 in 
D2FBS in the presence of 30 pg/ml DNase (from beef pancreas, noncrystalline, 1,180 Kunitz units/ 
mg protein; lot no. 73C-0320; Sigma Chemical Co., St. Louis, Mo.). The cells were then washed and 
resuspended to the desired concentration in D2FBS.  Controls were immune cells incubated with 
the antisera or C alone and untreated spleen cells from noninfected mice. 
Antigens.  Heat-killed trypanosomes  (HKT)  were obtained by mild heat-treatment (80°C/10 
min) of a suspension of 5  x  10  e culture forms/ml PBS (five times washed) of either Y or Tulahu~n 
strains; purified protein derivative of tuberculin (PPD),  2 mg/ml was obtained from Connaught 
Medical Research Laboratory,  Willowdale, Ontario, Canada. 
Reagents.  Acid-treated dog serum (AT-DS) was prepared by adjusting the pH of dog serum 
(GIBCO) to 2  with  2  N  HC1  in isotonic saline; after 30 rain at room temperature the pH  was 
adjusted to 7,4 with 2 N  NaOH in isotonic saline and filter sterilized. Polystyrene latex particles 
1.101  pm were obtained from Dow Diagnostics, Indianapolis, Ind. 
Fibrinolytic  Assay.  The assay was performed in a  two-step process.  First,  supernates were 
prepared  by  incubation  of cells  with  antigen.  These  supernates  were  then  added  to  normal, 
unstimulated  mouse  macrophages  plated  on  125I-fibrin-coated Linbro plates,  incubated for  1-3 
days, at the end of which fibrinolytic activity was assayed. 
PREPARATION OF SUPERNATES.  Control and T. cruzi-primed  total or fractionated peritoneal or 
spleen cells were incubated with the antigen at 37°C in a COs atmosphere for the desired period of 
time.  The supernates were then collected,  centrifuged at 750 g  for 15 min to  remove cells and 
debris,  and  millipored  in  a  0.45  izm  Millex  filter  (Millipore  Corp.,  Bedford,  Mass.).  These 174  MACROPHAGE  ACTIVATION 
supernates are  very  stable  upon  storage  at  -20°C  and  -70°C  and  activity  was  found  to  be 
preserved over 4 mo. 
INDUCTION OF FIBRINOLYTIC ACTIVITY IN UNSTIMULATED MACROPHAGES.  The supernates were 
added at the desired concentration to monolayers of normal macrophages (kept for 2 h at 37°C after 
explanting, washed twice in Hank's balanced salt solution (HBSS) to remove nonadherent cells), 
on 125I-fibrin-coated  Linbro wells, prepared as described (17). The plates contained 10 ~g fibrino- 
gen/cm  2 and 5  ×  10  ~ trypsin-releasable cpm. Supernatant concentration was 25%, unless stated 
otherwise. The ceils were incubated for 1-3 days in D2FBS. The flbrinolytic activity was then 
assayed by washing the cells twice in HBSS, followed by incubation in 0.5 ml Dulbecco's medium 
containing 5%  AT-DS.  100-~1 samples of medium were withdrawn and assayed for release of 
radioactivity in  a  Packard  gamma counter  (Packard Instruments, Inc.,  Downers Grove,  Ill.). 
Secretion of plasminogen activator was measured in samples of conditioned medium from normal 
macrohages exposed to the supernatant fluids, washed, and cultivated in serum-free medium for 
24 h  and assayed as previouly described (13). 
Results 
To  obtain  a  better  understanding of the  mechanisms involved  in  macro- 
phage activation, attempts were made to carry out this process under in vitro 
conditions.  Two parameters  of macrophage activation were of particular in- 
terest:  the  trypanocidal  activity  against  trypomastigotes  of  T.  cruzi  and 
secretion of plasminogen activator.  For this purpose,  a  two-step system was 
employed. First, peritoneal or spleen cells from mice infected with T. cruzi were 
incubated in vitro with HKT and cell-free supernatant fluids prepared.  Next, 
normal unstimulated macrophages were exposed to these supernatant fluids for 
varying periods of time. The cells were then either infected with T. cruzi  or 
assayed for enzymatic activity. No trypanocidal or trypanostatic activity has as 
yet been induced under these conditions. Because of  these difficulties  we chose to 
focus on the induction of enzyme secretion. 
Enhanced Secretion of Plasminogen Activator by Normal Macrophages  In- 
duced by Antigen-Stimulated Sensitized Cells.  Fig. 1 shows a representative 
experiment in which mixed peritoneal cells from 4-wk-infected mice were ex- 
posed in vitro to viable trypomastigotes of T. cruzi. 72 h later supernatant fluids 
were collected, millipored, and incubated for 3 days with normal macrophages. 
These cells exhibited a  10-fold increase in fibrinolytic activity. Similar results 
were obtained when HKT were used, indicating that the supernatant activity 
was not dependent on the living parasite. HKT were therefore used as antigen 
in all the subsequent experiments. Control supernates were obtained by incu- 
bating peritoneal cells from noninfected mice with the same antigens.  Addi- 
tional controls included supernatant fluids derived from the incubation of im- 
mune  or  control  cells  without  antigen  (S  No  Ag)  and  finally macrophages 
incubated without any added supernate  (No S).  No fibrinolysis was observed 
when supernates were added in the absence of macrophages. 
The  characteristics  of this  induced flbrinolytic activity in  normal  macro- 
phages was in all respects similar to that observed with in vivo activated cells 
and described in the accompanying paper  (13). The activity was plasminogen 
dependent, linear with time over the 5- to 6-h assay period, and predominantly 
associated with the extracellular medium. This suggests that the induced fibrin- 
olytic activity in these in vitro activated macrophages is due to an increased 
secretion of plasminogen activator. 
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Fro.  1.  Enhanced  fibrinolytic activity  by normal  macrophages induced by supernatant 
fluids from antigen-exposed sensitized peritoneal  cells from 4-wk T. cruzi-infected  mice. 
Antigens were live trypomastigotes  or heat-killed  mixed culture forms (HKT). HKT and T 
concentration was 5 × 10e/ml. IS, supernatant fluids from incubated sensitized cells with or 
without  antigen  exposure.  CS,  supernatant  fluids  from incubated  control cells with  or 
without antigen exposure. 
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FIo.  2.  In vitro time-course of  generation of active supernatant fluids and the induction of 
plasminogen activator secretion. 
ditions  were  sought for  both  the  production  of the  active  supernatant  fluids 
and the induction of plasminogen activator secretion by normal macrophages. 
Fig. 2 shows the time required for optimal activity in each of these parameters. 
Total peritoneal cells from 3-wk-infected mice were incubated for 24, 48, and 72 h 
with HKT. The resulting supernatant fluids were then incubated for 24, 48, and 176  MACROPHAGE  ACTIVATION 
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Fro.  3.  Temporal requirement for the sensitization of peritoneal cells.  Peritoneal cells 
were harvested from T. cruzi-infected mice 1-13 wk after infection and exposed to HKT in 
vitro.  Supernatant fluids  were  then incubated with  normal  macrophages for 48  h,  and 
fibrinolysis assayed. 
72 h with normal macrophages and secretion of plasminogen activator assayed. 
Although some enhancement  of plasminogen  activator secretion was noted as 
early  as  24  h,  optimal  supernatant  fluids  were  obtained  when  antigen  and 
sensitized peritoneal  cells were incubated  for 48 h.  Similarly  the  exposure of 
macrophages to these supernates for 48 h  yielded maximal values. 
Fig.  3 shows that total peritoneal cells were capable of producing the active 
supernatant  fluids,  when  exposed to  HKT,  as  early  as  1  wk  after  T.  cruzi 
infection. The activity peaked at 3 wk, and was absent from the 6th to 13th wk. 
This is in contrast with our findings in vivo in which peritoneal macrophages 
obtained after an intraperitoneal  challenge with HKT were active in secreting 
plasminogen activator for up to 14 wk after infection (13). Spleen cells were also 
capable of producing the supernatant factor and the activity was detectable from 
1 to  12  wk  postinfection  (Table  I).  A  sensitized  cell  population  is  therefore 
present in the spleen for up to 3 mo after infection,  whereas their peritoneal 
counterpart  disappears  after 6 wk. The decline in the supernatant  activity at 
high cell densities is presumably the result of poor viability under these condi- 
tions.  107  spleen  cells  therefore  appeared  to  be  optimal  under  the  culture 
conditions used. It should be pointed out that peritoneal cells are more efficient 
in producing the supernatant fluids on a per cell basis, since 4 ×  10  ~ unfraction- 
ated peritoneal cells yield comparable activity to 107 spleen cells. 
Specificity of the Production of Active Supernatant Fluids.  Initial  experi- 
ments  were designed to demonstrate  that  the  active supernatant  fluids were 
derived from a  specific interaction  of sensitized cells and antigen.  Spleen and 
peritoneal cells from T. cruzi- or BCG-infected mice were incubated in vitro with 
HKT, PPD, or latex particles for 48 h  and the supernates assayed on unstimu- 
lated macrophages. Table II shows that the active supernatant fluids were only 
elicited  by incubation  of immune  spleen  cells  with  the  sensitizing  antigen. 
Incubation  of T. cruzi-immune cells with PPD or of BCG-immune  cells with 
HKT did not elicit this activity. Neither did the addition of nonspecific particles 
in the form of polystyrene latex. These results indicated that nonspecific factors 
or phagocytosis of a  particulate  were not responsible for the production of the 
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TABLE  I 
The Ability of  Spleen Cells during a T. cruzi Infection to Produce 
Active Supernatant Fluids* 
Plasminogen activa- 
Duration of T. cruzi in-  No. of spleen cells  tor, % radioactivity 
fection  exposed to antigen  released/4 h/106 cells 
Control  5 x  l0  s  0.63 
5  x  106  0.57 
5 x  10'  0.69 
177 
T. cruzi 3 wk  5  ×  10  s  0.63 
5  ×  106  5.80 
5  ×  107  3.30 
T. cruzi 12 wk  5  ×  lO  s  1.75 
5  ×  106  5.21 
1 ×  107  9.70 
5  ×  107  3.34 
* Mice were injected intraperitoneally with 5  ×  108 culture forms of T. 
cruzi and 3 and 12 wk later their spleens removed, and serial dilutions 
of spleen cells incubated with 5 ×  105 HKT for 48 h. Supernates were 
collected and incubated with normal, unstimulated macrophages for 
48  h,  in  lzsI-fibrin-coated plates. The cells were then washed three 
times with HBSS and the assay started by adding Dulbecco's medium 
containing 5% AT-DS. 
TABLE  II 
The Role of Specific Antigen in the Production of Active 
Supernatant Fluid* 
Infection  Antigen added 
Plasminogen activator, 
% radioactivity re- 
leased/4 h/lO  6 cells 
Control  HKT  1.4 
PPD  1.7 
Latex  1.7 
BCG  HKT  1.8 
PPD  8.2 
Latex  1.8 
T. cruzi  HKT  10.0 
PPD  2.5 
Latex  1.0 
* Mice were infected 3 wk previously with either 5 × 106 culture forms of 
T. cruzi intraperitoneally or 2-4  x  107 viable BCG intravenously. 107 
spleen cells were incubated for 48 h with 5 x  10  s HKT, 5 ~g PPD, or 5 
x  106 latex particles. Supernates were collected and incubated for 48 h 
with normal unstimulated macrophages on a  l~sI-fibrin-coated plate 
and assayed for fibrinolytic activity. 
Dose-Response  Titration  of the  Supernatant  Fluids.  Fig.  4  shows  a  dose 
response titration obtained when different concentrations of spleen cell super- 
nates were added to unstimulated macrophages. Immune supernates at a  con- 
centration of 2.5% was enough to induce a significant enhancement of secretion. 178  MACROPHAGE  ACTIVATION 
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Fro.  4.  Dose-response titration of supernatant fluid activity. 107 spleen cells fore control 
mice or 3-wk T. cruzi-infected mice were exposed to HKT for 48 h. Supernatant fluids were 
added at different concentrations to 10  e unstimulated mouse peritoneal macrophages on 12sI- 
fibrin-coated plates and fibrinolytic activity assayed 48 h later. 
TABLZ  III 
The Ability of Supernatant Fluids to Stimulate Macrophages  of Other 
H-2 Specificities* 
Origin of active 
supernatant 
fluids 
Plasminogen activator, % radioactivity released/4 hi10  e 
cells 
Unstimulated macrophages from: 
NCS  C57/BL  A/J 
NCS  19.0 (1.3)  15.7 (2.7)  14.2 (3.3) 
C57BL/6J  15.3 (1.9)  16.2 (2.1)  14.4 (3.1) 
A/J  16.1 (2.3)  15.8 (1.5)  11.5 (2.0) 
* Mice were infected intraperitoneally with 5 ×  106 culture forms of T. cruzi 
and 3 wk later spleens were removed, and 107 spleen cells incubated with 5 × 
105 HKT for 48 h.  Supernates were then incubated for 48 h  with normal, 
unstimulated macrophages from NCS, C57BL/6J,  and A/J mice. Numbers in 
parentheses  represent  values  obtained by  incubating  macrophages  with 
supernates derived from antigen-exposed control spleen cells. 
The response  plateaued  at  about  50%  and  higher  concentrations  did not elicit 
any  further  increases in secretion.  Supernates  derived from the interaction  of 
nonimmune  spleen cells with antigen  (CS) had a  lower, but significant effect at 
concentrations  greater  than  50%.  All subsequent  experiments  were performed 
using a  concentration  of 25%. 
Effect of Supernatant Fluids on Allogeneic  Macrophages.  The induction of 
plasminogen  activator on unstimulated  macrophages  by the active supernatant 
fluids was independent  of histocompatibility differences in either spleen cells or 
macrophages.  These  results  are  illustrated  in Table III.  Similar  results  were NADIA  NOGUEIRA,  SIAMON  GORDON,  AND  ZANVIL  COHN 
TAB~z IV 
The Ability of  Anti-Thy 1.2 Serum to Suppress the Production of 
Active Supernatant Fluids* 
Infection  Treatment of  spleen cells 
Plasminogen ac- 
tivater,  %  radio- 
activity  released/ 
4 h/10  e  cells 
Control  1.4 
179 
T. cruzi  -  8.6 
Anti-Thy 1.2  9.5 
Complement  9.8 
Anti-Thy 1.2 + complement  2.6 
* 107 spleen cells from  either control or infected C3H/HeJ mice (5 x 106 
live culture forms of Y strain of T. cruzi injected intraperitoneally 4 
wk previously)  were incubated with anti-Thy 1.2 serum and rabbit C 
as described in the  Materials and Methods. After treatment,  cells 
were washed and incubated in  vitro for 48 h with 5 ×  105 HKT. 
Supernates were collected  and incubated for 48 h with normal macro- 
phages on a ~25I-fibrin-coated  plate and assayed for fibrinolytic activ- 
ity. 
obtained with supernates obtained from C3H/HeJ mice tested on NCS macro- 
phages (not shown). 
The Requirement for T L ymphocytes in the Production of Active Supernatant 
Fluids.  Lymphocytes were the obvious candidates to produce such activating 
factor(s). To confirm this, initial experiments were performed to test the ability 
of  nylon-wool separated peritoneal or spleen cells to generate the active superna- 
tant fluids. This procedure has been shown to result in depletion of macrophages 
and B lymphocytes and an enrichment of T lymphocytes in the column effluent 
(18). Nylon-wool-separated peritoneal or spleen cells were indeed able to gener- 
ate the active supernatant fluids. 
More definitive experiments were then performed by using a  specific anti- 
thymocyte serum, kindly supplied by Dr. U. H~mmerling of the Sloan-Kettering 
Cancer Institute. A  1:10 dilution of this antiserum, in the presence of rabbit C, 
killed 25-30% of  spleen cells, as determined by trypan-blue exclusion. As seen in 
Table IV, pretreatment of spleen cells with anti-Thy 1.2 serum and C suppressed 
the production of the active supernates. This indicates that T cells are required 
for the generation of  this factor(s). Pretreatment of spleen cells with either anti- 
Thy 1.2 serum or C alone had no effect on the generation of the active superna- 
tant fluids. 
Treatment of spleen cells with anti-K serum and C did not affect significantly 
the production of the supernatant factors. Such anti-K and C-treated spleen cells 
were,  however,  able  to  reconstitute the  activity of a  spleen  cell  population 
previously treated  with  anti-Thy  1.2  serum  and  C.  This  suggests  that  the 
suppression obtained with killing of T lymphocytes is indeed due to a  require- 
ment for these cells and not due to inhibition by factors released by the lysed 
cells. 180  MACROPHAGE  ACTIVATION 
Discussion 
Macrophages activated by the intraperitoneal injection  of thioglycollate  me- 
dium (17)  or after  a secondary intraperitoneal challenge in  the course of  a BCG 
or T. cruzi infection (13)  secrete large amounts of  plasminogen activator.  The 
immunological specificity  exhibited in the induction of  plasminogen activator 
secretion and trypanocidal activities  in these macrophages suggested that this 
could be the result of the influx of sensitized lymphocytes and the release of 
mediators upon contact with antigen. If  that was the case then we would expect 
that sensitized  lymphocytes should be able to  generate these mediators in  vitro, 
upon exposure to the appropriate antigen. In addition, the incubation of such 
lymphocyte  products with unstimulated  macrophages  in vitro should elicit 
similar activated properties. Indeed,  our results show that the exposure of 
sensitized  peritoneal or spleen cells  to the specific  antigen leads to the genera- 
tion of factor(s) that induce the secretion of large amounts  of plasminogen 
activator  by unstimulated macrophages. In addition,  this  activating factor(s)  is 
generated by macrophage-depleted cell  populations and requires T lymphocytes 
for its production. Recent work has provided evidence that other lymphokines 
such as migration inhibitory factor (MIF) (19-22), mitogenic factor (23, 24), 
lymphotoxin (25),  and chemotactic factor  (26)  can be produced by B as well as T 
lymphocytes. Bloom and Shevach (27)  have recently reported that B lympho- 
cytes can only be stimulated by antigen in  the presence of  T cells  and that MIF 
production is  a thymus-dependent response. We have described a T-cell  require- 
ment for  the production of  the macrophage induction factor(s),  but have not yet 
excluded the possibility  that other cell  types may be involved in its  production. 
A variety of  other macrophage secretory products has been described (28)  and 
it would be of  interest  to know if  these are also  released by the addition of  the 
lymphocyte factor(s).  Enhanced secretion of collagenase by guinea pig perito- 
neal exudate cells  exposed to  antigen-stimulated spleen cell  supernates has  been 
reported previously  (29). Induction of macrophage  plasminogin  activator by 
lectin-stimulated spleen cell  supernates has also  been recently described (30). 
There are a number of  advantages in using plasminogen-activator induction 
to study the influence of lymphokines on the activation of  normal macrophage 
populations. These include:  First,  the sensitivity  of  the fibrinolytic  system allows 
accurate  quantitation  of the activity of this factor(s), which  has not been 
possible  in other systems. None of  the systems previously described to evaluate 
lymphokine(s) activity  such as MIF, macrophage chemotactic factor,  and lym- 
photoxin provide a precise dose-response  relationship. Under  the conditions 
employed,  a 2.5% concentration  of the active supernatant fluid produced an 
easily  detectable response and maximum  secretion  occurred at a 50% concentra- 
tion. This dose-response  relationship may be explained either by quantitative 
alterations  in  the level  of  secretion  and/or the  recruitment of  new secretory cells 
in response to increasing levels of the factor.  A  recent report (30)  favors the 
latter  possibility:  using a lectin-stimulated spleen cell  supernate and a casein- 
agar procedure that detects 5brinolysis in single cells, a majority of macro- 
phages was found to  be secreting  plasminogen activator  after  induction.  A second 
advantage is  that it  allows the study of  the cell  types involved in  the generation 
of the factor. In particular it can employ homogeneous  cell  populations and 
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This is an advantage not only of the assay system but of the mouse model in 
general.  Finally, it  would be  of considerable interest to  examine these  cell 
populations with more highly defined antigens. 
The fact that neither trypanostatic nor trypanocidal activity could be induced 
by this  factor(s)  in unstimulated resident macrophages suggests that  either 
other mediators are required for these properties to be expressed and/or that 
macrophages must undergo metabolic and functional changes to become respon- 
sive to the lymphocyte supernatant factor(s). This could occur for example when 
exposed  to  a  nonspecific inflammatory environment.  In this  regard,  it  is  of 
interest that in every instance in which an in vitro microbistatic or microbicidal 
activity has been generated against protozoa, macrophages were obtained from 
peritoneal exudates, sensitized animals, or had been manipulated in vitro by 
exposure to heart-infusion broth, thioglycollate medium, or Ficoll-Hypaque (4, 
6-8,  31). Efforts are  in  progress  to  define the  conditions under  which  a  try- 
panocidal activity can be evoked under in vitro conditions. 
Summary 
In this article we describe methods in which unstimulated mouse peritoneal 
macrophages were induced to secrete high levels of  plasminogen activator under 
in vitro conditions. The exposure of sensitized peritoneal or spleen cell popula- 
tions from Trypanosoma  cruzi-infected  animals to either viable or heat-killed 
trypanosomes lead to the release of an inducing factor(s).  Maximal levels of 
plasminogen activator secretion are achieved by the incubation of such factor(s) 
with unstimulated macrophages for  48  h.  A  significant increase  in  enzyme 
secretion was already observed after a  24 h  incubation. The production of the 
inducing factor(s) by sensitized cells was immunologically  specific and unrelated 
antigens did not stimulate the production of the factor(s) by sensitized perito- 
neal or spleen cell populations. The inducing factor(s) was produced by nylon- 
wool-fractionated spleen and peritoneal cells which had been depleted of macro- 
phages. Pretreatment of sensitized spleen cells with anti-0 serum and C abol- 
ished the production of the activating factor(s). The active supernatant fluids 
were able to induce secretion of macrophage plasminogen activator across H-2 
barriers. Attempts to induce trypanocidal activity in unstimulated macrophages 
have not been successful. 
We want to thank  Ms. Marianne Polimeni for excellent technical assistance and Ms.  Grace 
Silvestri for typing the manuscript. 
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